ATE337331T1 - Pyrrolidincarbonylamin-enthaltende cyclische peptid-disulfide als antagonists von vcam-vla4 - Google Patents

Pyrrolidincarbonylamin-enthaltende cyclische peptid-disulfide als antagonists von vcam-vla4

Info

Publication number
ATE337331T1
ATE337331T1 AT00929365T AT00929365T ATE337331T1 AT E337331 T1 ATE337331 T1 AT E337331T1 AT 00929365 T AT00929365 T AT 00929365T AT 00929365 T AT00929365 T AT 00929365T AT E337331 T1 ATE337331 T1 AT E337331T1
Authority
AT
Austria
Prior art keywords
carbonylamin
vla4
vcam
pyrrolidine
antagonists
Prior art date
Application number
AT00929365T
Other languages
English (en)
Inventor
Li Chen
Nader Fotouhi
David Young Jackson
Jefferson Wright Tilley
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE337331T1 publication Critical patent/ATE337331T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT00929365T 1999-04-20 2000-04-17 Pyrrolidincarbonylamin-enthaltende cyclische peptid-disulfide als antagonists von vcam-vla4 ATE337331T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13021599P 1999-04-20 1999-04-20

Publications (1)

Publication Number Publication Date
ATE337331T1 true ATE337331T1 (de) 2006-09-15

Family

ID=22443611

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00929365T ATE337331T1 (de) 1999-04-20 2000-04-17 Pyrrolidincarbonylamin-enthaltende cyclische peptid-disulfide als antagonists von vcam-vla4

Country Status (15)

Country Link
US (1) US6265572B1 (de)
EP (1) EP1171452B1 (de)
JP (1) JP2002542256A (de)
KR (1) KR100636481B1 (de)
CN (1) CN1167710C (de)
AR (1) AR023546A1 (de)
AT (1) ATE337331T1 (de)
AU (1) AU769294B2 (de)
BR (1) BR0009838A (de)
CA (1) CA2370259A1 (de)
DE (1) DE60030266T2 (de)
ES (1) ES2269141T3 (de)
TR (1) TR200103004T2 (de)
WO (1) WO2000063234A2 (de)
ZA (1) ZA200108018B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6939855B2 (en) * 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
US20090043126A1 (en) * 2005-02-28 2009-02-12 Jordi Bosch I Llado Process and Methods for the Preparation of Gabapentin and Its Intermediates
AU2008219007A1 (en) 2007-02-20 2008-08-28 Merrimack Pharmaceuticals, Inc. Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
JP5639039B2 (ja) 2008-04-11 2014-12-10 メリマック ファーマシューティカルズ インコーポレーティッド ヒト血清アルブミンリンカーおよびそのコンジュゲート
CN102282168A (zh) 2008-11-18 2011-12-14 梅里麦克制药股份有限公司 人血清白蛋白接头以及其结合物
WO2013057096A1 (en) 2011-10-17 2013-04-25 Westfaelische Wilhelms-Universitaet Muenster Assessment of pml risk and methods based thereon
US9345766B2 (en) 2012-08-30 2016-05-24 Merrimack Pharmaceuticals, Inc. Combination therapies comprising anti-ERBB3 agents
WO2020092401A1 (en) 2018-10-30 2020-05-07 Gilead Sciences, Inc. COMPOUNDS FOR INHIBITION OF ALPHA 4β7 INTEGRIN
WO2020092394A1 (en) 2018-10-30 2020-05-07 Gilead Sciences, Inc. Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
ES2987796T3 (es) 2018-10-30 2024-11-18 Gilead Sciences Inc Derivados de N-benzoil-fenilalanina como inhibidores de la integrina alfa4beta7 para el tratamiento de enfermedades inflamatorias
DK3873884T3 (da) 2018-10-30 2025-02-17 Gilead Sciences Inc 3-(quinolin-8-yl)-1,4-dihydropyrido[3,4-d]pyrimidin-2,4-dion-derivater som alpha4beta7-integrinhæmmere til behandling af inflammatoriske sygdomme
AU2020329207B2 (en) 2019-08-14 2024-02-29 Gilead Sciences, Inc. Compounds for inhibition of alpha 4 beta 7 integrin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds

Also Published As

Publication number Publication date
DE60030266D1 (de) 2006-10-05
EP1171452B1 (de) 2006-08-23
CN1167710C (zh) 2004-09-22
DE60030266T2 (de) 2007-07-19
US6265572B1 (en) 2001-07-24
WO2000063234A2 (en) 2000-10-26
KR20010108517A (ko) 2001-12-07
ES2269141T3 (es) 2007-04-01
KR100636481B1 (ko) 2006-10-18
CN1347419A (zh) 2002-05-01
CA2370259A1 (en) 2000-10-26
TR200103004T2 (tr) 2002-01-21
WO2000063234A3 (en) 2001-01-18
AR023546A1 (es) 2002-09-04
EP1171452A2 (de) 2002-01-16
AU769294B2 (en) 2004-01-22
AU4748200A (en) 2000-11-02
ZA200108018B (en) 2003-03-26
BR0009838A (pt) 2002-01-08
JP2002542256A (ja) 2002-12-10

Similar Documents

Publication Publication Date Title
ATE239011T1 (de) Neuartige form von s-omeprazol
ATE421973T1 (de) Inzektizide proteinen von bacillus thuringiensis
ATE522504T1 (de) Pyrrolidin- und piperidinderivate als nk1- antagonisten
DE60018372D1 (de) Oralzusammensetzung als mikroemulsion von silybin
DE60039446D1 (de) Cyclische aminverbindung als ccr5 antagonist
DE60112276D1 (de) Elektrophoretische trennung von verbindungen
ID24481A (id) Gastrokinetik monosiklik benzamida dari derivat-3-atau-tersubstitusi 4-(aminometil)-piperidin
DE50002364D1 (de) Abgewandelte aminosäureamide als cgrp antagonisten
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DK1066258T3 (da) Arylphenylsubstituerede cycliske ketoenoler
NO20014970D0 (no) Cyklisk protein-tyrosin-kinase-inhibitor
DE60021070D1 (de) Kodierung von mikroträgern
DE50012379D1 (de) Verwendung von nanoskaligen antischuppenwirkstoffen
DE60227686D1 (de) Mischungen von cyclosporin-analogen und ihre verwendung als immunmodulatoren
DE60015725D1 (de) Erzeugung von werkstoffen
DE69903410D1 (de) Entkarbonisierung von gasen unter verwendung von zeolithischen adsorptionsmitteln
DE60127473D1 (de) Abscheidung von Gamma-Al2O3 mittels CVD
ATE260274T1 (de) Furanonderivate als inhibitoren von cathepsin s
DE60204093D1 (de) Substanzgemisch von Triphenylamindimeren
DE60127311D1 (de) Verbesserung von luftbleichkatalysatoren
DE60129572D1 (de) Verwendung von antikörpern gegen spezifische mhc-peptidkomplexe
IS2230B (is) Aukinn stöðugleiki lausna til inndælingar
DE60030266D1 (de) Pyrrolidincarbonylamin-enthaltende cyclische peptid-disulfide als antagonists von vcam-vla4
EP1173467A4 (de) Von chemokinen abgeleitete synthetische peptide
AT5762U3 (de) Entleerung von grossbehältern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1171452

Country of ref document: EP

REN Ceased due to non-payment of the annual fee